Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Guidelines search

Búsqueda de Guías

  • Perinatal HIV Clinical Guidelines (93)
  • HIV Clinical Guidelines: Pediatric ARV (84)
  • HIV Clinical Guidelines: Adult and Adolescent ARV (67)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (44)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (40)
  • Guidance for Caring for People With HIV Displaced by Disasters (4)
Resultados de la búsqueda 321 – 339 de 339
Table 4. Significant Pharmacokinetic Interactions Between Drugs Used to Treat or Prevent Opportunistic Infections
Appendix E. Archived Sections
Overview
Table 5. Serious and/or Common Adverse Reactions Associated with Systemically Administered Drugs Used to Treat or Prevent Opportunistic Infections
Table 6. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections that Require Dosage Adjustment in Adults With Renal Insufficiency
Human Herpesvirus 8
Influenza
Mpox
Progressive Multifocal Leukoencephalopathy
Figures
Tables
Appendix A: List of Abbreviations
Figure 1. Recommended Immunization Schedule for Children with HIV Infection Aged 0 through 18 Years; United States, 2025
Table 1. Primary Prophylaxis
Table 2. Secondary Prophylaxis
Table 3. Treatment
Table 4. Common Drugs Used for Treatment of Opportunistic Infections in Children With HIV: Preparations and Major Toxicities
Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections
Appendix B: Panel Roster and Financial Disclosures

Paginación

  • Primera página ‹‹
  • Página anterior ‹
  • …
  • Página 13
  • Página 14
  • Página 15
  • Página 16
  • Página actual 17

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.